الفهرس | Only 14 pages are availabe for public view |
Abstract It was shown that the Basal AFU had significantly high diagnostic performance in predicting the diagnosis of failure of treatment at cut off value of >12.5 with sensitivity 100% and specificity was 92%. While AFU after intervention had significant moderate performance in predicting the diagnosis of recurrence at cut off value of > 7.5 with sensitivity 80% and specificity was 92%. After intervention, AFU was significantly decreased in both treated and those who failed to treat groups. In conclusion, AFU can be used as a biomarker for hepatocellular carcinoma with a good diagnostic and prognostic value. |